ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Zyus Life Sciences Corporation

Zyus Life Sciences Corporation (ZYUS)

0,80
0,00
(0,00%)
Fermé 19 Décembre 10:00PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
0,80
Prix Achat
0,79
Prix Vente
0,95
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,70 Plage de 52 semaines 1,19
Cap du marché
Clôture Veille
0,80
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
3 501
Actions en circulation
70 847 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,33
Bénéfice par action (BPA)
-0,6
Chiffre d'affairess
351k
Bénéfice net
-42,59M

À propos de Zyus Life Sciences Corporation

Secteur
Pharmaceutical Preparations
Industrie
Oil And Gas Field Expl Svcs
Site Web
Siège social
Toronto, Ontario, Can
Fondé
2023
Zyus Life Sciences Corporation est coté dans le secteur Pharmaceutical Preparations de la TSX Venture Exchange avec le ticker ZYUS. Le dernier cours de clôture d'Zyus Life Sciences était de $0,80. Au cours de la dernière année, les actions de Zyus Life Sciences ont été négociées dans une fourchette de prix de $ 0,70 à $ 1,19.

Zyus Life Sciences compte actuellement 70 847 000 actions en circulation. La capitalisation boursière d'Zyus Life Sciences est de $56,68 million. Zyus Life Sciences a un ratio cours/bénéfice (ratio PE) de -1.33.

ZYUS Dernières nouvelles

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSXV: ZYUS) is pleased to announce that Brent Zettl, President and CEO of ZYUS, will present and host one-on-one meetings with investors...

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Receives Patent from United States Patent and Trademark Office (“USPTO”) Supporting ZYUS’ Lead Drug Candidate ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

Dr. Clarke Joins ZYUS’ Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced team ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life...

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

Completion of Phase 1 and Supportive Preclinical Data Will Assist in Ongoing Phase 2 Clinical Development of ZYUS’ Lead Drug Product Candidate ZYUS Life Sciences Corporation ("ZYUS" or the...

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

Mr. Miller brings nearly two decades of knowledge, experience and expertise to ZYUS ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company...

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based...

ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

Mr. Brownlee brings more than 30 years of knowledge, experience and expertise to ZYUS’ Board of Directors ZYUS Life Sciences Corp. ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.12-13.04347826090.920.920.821700.81953917CS
4-0.05-5.882352941180.8510.7533230.88118614CS
12-0.07-8.045977011490.8710.735010.82561408CS
26-0.21-20.79207920791.011.050.739020.87738212CS
52-0.11-12.08791208790.911.190.757010.9528505CS
156-1.7-682.52.50.793131.0999959CS
260-1.7-682.52.50.793131.0999959CS

ZYUS - Frequently Asked Questions (FAQ)

What is the current Zyus Life Sciences share price?
The current share price of Zyus Life Sciences is $ 0,80
How many Zyus Life Sciences shares are in issue?
Zyus Life Sciences has 70 847 000 shares in issue
What is the market cap of Zyus Life Sciences?
The market capitalisation of Zyus Life Sciences is CAD 56,68M
What is the 1 year trading range for Zyus Life Sciences share price?
Zyus Life Sciences has traded in the range of $ 0,70 to $ 1,19 during the past year
What is the PE ratio of Zyus Life Sciences?
The price to earnings ratio of Zyus Life Sciences is -1,33
What is the cash to sales ratio of Zyus Life Sciences?
The cash to sales ratio of Zyus Life Sciences is 160
What is the reporting currency for Zyus Life Sciences?
Zyus Life Sciences reports financial results in CAD
What is the latest annual turnover for Zyus Life Sciences?
The latest annual turnover of Zyus Life Sciences is CAD 351k
What is the latest annual profit for Zyus Life Sciences?
The latest annual profit of Zyus Life Sciences is CAD -42,59M
What is the registered address of Zyus Life Sciences?
The registered address for Zyus Life Sciences is 3400-22 ADELAIDE STREET W, TORONTO, ONTARIO, M5H 4E3
What is the Zyus Life Sciences website address?
The website address for Zyus Life Sciences is www.zyus.com
Which industry sector does Zyus Life Sciences operate in?
Zyus Life Sciences operates in the OIL AND GAS FIELD EXPL SVCS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AAAAAuralite Investments Inc
$ 0,265
(0,00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0,04
(0,00%)
0
AAAlba Minerals Ltd
$ 0,03
(0,00%)
0
A.HArmor Minerals Inc
$ 0,40
(0,00%)
0
AArmor Minerals Inc
$ 0,45
(0,00%)
0
AAAAAuralite Investments Inc
$ 0,265
(0,00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0,04
(0,00%)
0
AAAlba Minerals Ltd
$ 0,03
(0,00%)
0
A.HArmor Minerals Inc
$ 0,40
(0,00%)
0
AArmor Minerals Inc
$ 0,45
(0,00%)
0
AAAAAuralite Investments Inc
$ 0,265
(0,00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0,04
(0,00%)
0
AAAlba Minerals Ltd
$ 0,03
(0,00%)
0
A.HArmor Minerals Inc
$ 0,40
(0,00%)
0
AArmor Minerals Inc
$ 0,45
(0,00%)
0
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock